Epigallocatechin-3-gallate directly suppresses T cell proliferation through impaired IL-2 utilization and cell cycle progression.
暂无分享,去创建一个
Dayong Wu | Z. Ren | S. Meydani | M. Meydani | F. Shang | Munkyong Pae
[1] Dayong Wu,et al. Green tea EGCG suppresses T cell proliferation through impairment of IL-2/IL-2 receptor signaling. , 2009, Free radical biology & medicine.
[2] D. Dickinson,et al. Effects of oral consumption of the green tea polyphenol EGCG in a murine model for human Sjogren's syndrome, an autoimmune disease. , 2008, Life sciences.
[3] M. Kurosaka,et al. (-)-Epigallocatechin-3-gallate suppresses osteoclast differentiation and ameliorates experimental arthritis in mice. , 2008, Arthritis and rheumatism.
[4] G. Opelz,et al. Proteasome inhibition suppresses essential immune functions of human CD4+ T cells , 2008, Immunology.
[5] Chi Chen,et al. Epigallocatechin-3-gallate ameliorates rats colitis induced by acetic acid. , 2008, Biomedicine & pharmacotherapy = Biomedecine & pharmacotherapie.
[6] Timothy J. Burroughs,et al. Therapeutic effect of epigallocatechin-3-gallate in a mouse model of colitis. , 2008, European journal of pharmacology.
[7] Chung S. Yang,et al. DOSE-DEPENDENT LEVELS OF EPIGALLOCATECHIN-3-GALLATE IN HUMAN COLON CANCER CELLS AND MOUSE PLASMA AND TISSUES , 2006, Drug Metabolism and Disposition.
[8] P. Kloetzel,et al. Green Tea Epigallocatechin-3-Gallate Mediates T Cellular NF-κB Inhibition and Exerts Neuroprotection in Autoimmune Encephalomyelitis1 , 2004, The Journal of Immunology.
[9] K. Schneider,et al. Allometric principles for interspecies extrapolation in toxicological risk assessment--empirical investigations. , 2004, Regulatory toxicology and pharmacology : RTP.
[10] R. Eckert,et al. Epigallocatechin-3-gallate Inhibits Epidermal Growth Factor Receptor Signaling Pathway , 2004, Journal of Biological Chemistry.
[11] Y. Oh,et al. Epigallocatechin-3-gallate, constituent of green tea, suppresses the LPS-induced phenotypic and functional maturation of murine dendritic cells through inhibition of mitogen-activated protein kinases and NF-κB , 2004 .
[12] H. Nagawa,et al. Epigallocatechin gallate, the main component of tea polyphenol, binds to CD4 and interferes with gp120 binding. , 2003, The Journal of allergy and clinical immunology.
[13] J. Girault,et al. A Single Ascending Dose Study of Epigallocatechin Gallate in Healthy Volunteers , 2003, The Journal of international medical research.
[14] E. Lam,et al. Commitment Point during G0→G1 That Controls Entry into the Cell Cycle , 2003, Molecular and Cellular Biology.
[15] S. John,et al. IL-2 Receptor Blockade Inhibits Late, But Not Early, IFN-γ and CD40 Ligand Expression in Human T Cells: Disruption of Both IL-12-Dependent and -Independent Pathways of IFN-γ Production , 2002, The Journal of Immunology.
[16] S. Kittur,et al. In vitro immunomodulatory effects of ten commonly used herbs on murine lymphocytes. , 2002, Journal of alternative and complementary medicine.
[17] Q. Dou,et al. Synthetic Analogs of Green Tea Polyphenols as Proteasome Inhibitors , 2002, Molecular medicine.
[18] V. Adhami,et al. Role of the retinoblastoma (pRb)-E2F/DP pathway in cancer chemopreventive effects of green tea polyphenol epigallocatechin-3-gallate. , 2002, Archives of biochemistry and biophysics.
[19] D. Fuchs,et al. Aqueous extracts of Crinum latifolium (L.) and Camellia sinensis show immunomodulatory properties in human peripheral blood mononuclear cells. , 2001, International immunopharmacology.
[20] J. Wu,et al. Proteasome activity is required for T lymphocyte aggregation after mitogen activation , 2001, Journal of cellular biochemistry.
[21] David M. Smith,et al. Ester Bond-containing Tea Polyphenols Potently Inhibit Proteasome Activity in Vitro and in Vivo * , 2001, The Journal of Biological Chemistry.
[22] S. Gupta,et al. Prevention of collagen-induced arthritis in mice by a polyphenolic fraction from green tea. , 1999, Proceedings of the National Academy of Sciences of the United States of America.
[23] W. Duguid,et al. Role of proteasomes in T cell activation and proliferation. , 1998, Journal of immunology.
[24] K. Nakagawa,et al. Dose-dependent incorporation of tea catechins, (-)-epigallocatechin-3-gallate and (-)-epigallocatechin, into human plasma. , 1997, Bioscience, biotechnology, and biochemistry.
[25] J. Roberts,et al. Inactivation of a Cdk2 inhibitor during interleukin 2-induced proliferation of human T lymphocytes , 1994, Molecular and cellular biology.
[26] P. G. Reeves,et al. AIN-93 purified diets for laboratory rodents: final report of the American Institute of Nutrition ad hoc writing committee on the reformulation of the AIN-76A rodent diet. , 1993, The Journal of nutrition.
[27] T. Shimamura,et al. Mitogenic activity of (-)epigallocatechin gallate on B-cells and investigation of its structure-function relationship. , 1992, International journal of immunopharmacology.
[28] K. Onoue,et al. Signal delivery by physical interaction and soluble factors from accessory cells in the induction of receptor-mediated T-cell proliferation. Synergistic effect of BSF-2/IL-6 and IL-1. , 1989, Immunology.
[29] Y. Yamamoto,et al. Requirement for delivery of signals by physical interaction and soluble factors from accessory cells in the induction of receptor-mediated T cell proliferation. Effectiveness of IFN-gamma modulation of accessory cells for physical interaction with T cells. , 1989, Journal of immunology.
[30] W. Leonard,et al. Interleukin 2 receptor gene expression in normal human T lymphocytes. , 1985, Proceedings of the National Academy of Sciences of the United States of America.
[31] E. Reinherz,et al. Triggering of the T3-Ti antigen-receptor complex results in clonal T-cell proliferation through an interleukin 2-dependent autocrine pathway. , 1984, Proceedings of the National Academy of Sciences of the United States of America.
[32] T. Waldmann,et al. Blockade of the interleukin-2 receptor by anti-Tac antibody: inhibition of human lymphocyte activation. , 1983, Journal of immunology.
[33] H. Nagawa,et al. Epigallocatechin gallate affects human dendritic cell differentiation and maturation. , 2008, The Journal of allergy and clinical immunology.
[34] T. Shimamura,et al. Mechanism of Action and Potential for Use of Tea Catechin as an Antiinfective Agent , 2007 .
[35] R. Goldfarb,et al. Differential effects of proteasome inhibitors on cell cycle and apoptotic pathways in human YT and Jurkat cells , 2006, Journal of cellular biochemistry.
[36] S. John,et al. IL-2 receptor blockade inhibits late, but not early, IFN-gamma and CD40 ligand expression in human T cells: disruption of both IL-12-dependent and -independent pathways of IFN-gamma production. , 2002, Journal of immunology.
[37] B. Nelson,et al. Biology of the interleukin-2 receptor. , 1998, Advances in immunology.